A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...

Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...

Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

In addition, they often have milder symptoms, especially in the early stages ... have a different prognosis and do not ...

Israeli scientists have identified a promising new factor in the pathology of Parkinson’s disease that could pave the way for ...

Nightmares can be caused by a range of conditions from Parkinson's to sleep apnoea - and they can even help diagnose your ...

(Image Credits: Pixabay) Parkinson’s disease (PD) therapeutic landscape is heavily genericized, leaving substantial unmet needs in neuroprotective and disease-modifying therapies (DMTs). With current ...

Symptoms of Parkinson's disease vary from person to person ... on several tests during the diagnosis process: "The mainstay of treatment are symptomatic treatments," Dr. Khurana says.

Among the symptoms, losing one's sense of smell could be an easily missed early indicator. The University of Auckland ...

Early initiation of pimavanserin among patients with Parkinson disease psychosis were more likely to experience complete symptom resolution.

"For too long, the Parkinson's community has had limited treatment options for advanced disease," Dr. Robert ... the drug provided more "on" time where symptoms were relieved with less "off ...